Val-Cit-PAB-MMAE
Val-Cit-PAB-MMAE is a drug-linker conjugate for antibody-drug conjugates (ADCs), comprising the protease-cleavable Val-Cit-PAB linker and the cytotoxic payload monomethyl auristatin E (MMAE) . MMAE potently inhibits tubulin polymerization, disrupting mitosis. This conjugate is widely used in ADC research for targeted cancer therapy, enabling the evaluation of drug delivery and efficacy in both in vitro and in vivo models.
Product Specifications
CAS Number
644981-35-1
Product Name Alternative
Auristatin, DrugLinkerConjugatesforADC, Drug-Linker Conjugates for ADC, DrugLinker Conjugates for ADC, inhibit, Inhibitor, Val Cit PAB MMAE, ValCitPABMMAE, Val-Cit-PAB-MMAE
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Purity
99.06% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (4.45 mM) ; DMSO:49 mg/mL (43.62 mM)
Smiles
CC[C@H] (C) [C@@H] ([C@@H] (CC (=O) N1CCC[C@H]1[C@H] (OC) [C@@H] (C) C (=O) N[C@H] (C) [C@@H] (O) c1ccccc1) OC) N (C) C (=O) [C@@H] (NC (=O) [C@H] (C (C) C) N (C) C (=O) OCc1ccc (NC (=O) [C@H] (CCCNC (N) =O) NC (=O) [C@@H] (N) C (C) C) cc1) C (C) C
Molecular Formula
C58H94N10O12
Molecular Weight
1123.43
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC403678 20 µg
Aurora A (AURKA) (NM_198433) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNCB1395-100 1x 100 µL
CD31 / PECAM-1 (Endothelial Cell Marker) (C31/1395R), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040484-500 1x 500 µL
Progesterone Receptor (PR484), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details